A Saskatoon company that develops surgical products has reached a major milestone. Ade Therapeutics has been given the go ahead by Health Canada to conduct clinical trials.
It's developed a technology that could help prevent internal scarring after surgery. Studies show scarring occurs in 93 per cent of surgeries and can lead to other complications.
Ade Therapeutics has secured US funding to start the human trial stage of the product in Saskatoon.
Sanj Singh, CEO of Ade Therapeutics, says this product would have the most benefit for the patient. "If you can help a patient not come back to the hospital for a second procedure, there are benefits to their own family looking after them, benefits to the place they work at, and benefits to the health care system because we're not dealing with these complications in a more expensive way."
